Infinity Pharmaceuticals, Inc. Proceeds from Stock Plans
Infinity Pharmaceuticals, Inc. reported Proceeds from Stock Plans of $146.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2018-03-15
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2017-12-31 was $146.00K, a 53.50% decline year-over-year.
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2017-09-30 was $0.00.
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2016-12-31 was $314.00K, a 86.68% decline year-over-year.
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for the quarter ending 2016-09-30 was $0.00.
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2017 was $146.00K, a 56.02% decline from fiscal 2016.
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2016 was $332.00K, a 88.27% decline from fiscal 2015.
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2015 was $2.83M, a 238.52% increase from fiscal 2014.
- Infinity Pharmaceuticals, Inc. proceeds from stock plans for fiscal 2014 was $836.00K, a 123.53% increase from fiscal 2013.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month | Proceeds from Stock Plans 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $146.00K derived: sum of 2 quarters · filed 2018-03-15 | $146.00K 10-K · filed 2018-03-15 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | ||||
| 2016-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $314.00K derived: sum of 2 quarters · filed 2018-03-15 | $332.00K 10-K · filed 2018-03-15 | $18.00K 10-K · filed 2017-03-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $18.00K 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | $18.00K 10-Q · filed 2017-08-03 | ||||
| 2015-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.36M derived: sum of 2 quarters · filed 2018-03-15 | $2.83M 10-K · filed 2018-03-15 | $964.00K 10-K · filed 2016-02-23 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $472.00K 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $472.00K 10-Q · filed 2016-08-09 | ||||
| 2014-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $443.00K derived: sum of 2 quarters · filed 2017-03-14 | $836.00K 10-K · filed 2017-03-14 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $393.00K 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | $393.00K 10-Q · filed 2015-08-06 | ||||
| 2013-12-31 | $374.00K 10-K · filed 2016-02-23 |